Issue 2/2013
Content (26 Articles)
Recent advances in research on epigenetic alterations and clinical significance of para-aortic lymphadenectomy in endometrial cancer: an introduction
Noriaki Sakuragi
MicroRNAs in endometrial cancer
Kouji Banno, Megumi Yanokura, Iori Kisu, Wataru Yamagami, Nobuyuki Susumu, Daisuke Aoki
The role of para-aortic lymphadenectomy in endometrial cancer
Mariam M. AlHilli, Andrea Mariani
Randomized controlled trial versus comparative cohort study in verifying the therapeutic role of lymphadenectomy in endometrial cancer
Yukiharu Todo, Noriaki Sakuragi
Clinical impact of c-Met expression and its gene amplification in hepatocellular carcinoma
Shunsuke Kondo, Hidenori Ojima, Hitoshi Tsuda, Jun Hashimoto, Chigusa Morizane, Masafumi Ikeda, Hideki Ueno, Kenji Tamura, Kazuaki Shimada, Yae Kanai, Takuji Okusaka
Impact of a multidisciplinary tumour board meeting for upper-GI malignancies on clinical decision making: a prospective cohort study
Pieter van Hagen, Manon C. W. Spaander, Ate van der Gaast, Caroline M. van Rij, Hugo W. Tilanus, J. Jan B. van Lanschot, Bas P. L. Wijnhoven
Health-related quality of life in Japanese patients with metastatic renal cell carcinoma treated with sunitinib
Hideaki Miyake, Ken-ichi Harada, Yuji Kusuda, Masato Fujisawa
A phase II study to evaluate the efficacy and toxicity of oxaliplatin in combination with gemcitabine in carcinoma of unknown primary
Heather Carlson, Renato Lenzi, Martin N. Raber, Gauri R. Varadhachary
Detection of hepatocellular carcinomas with near-infrared fluorescence imaging using indocyanine green: its usefulness and limitation
Yoshifumi Morita, Takanori Sakaguchi, Naoki Unno, Yasushi Shibasaki, Atsushi Suzuki, Kazuhiko Fukumoto, Keisuke Inaba, Satoshi Baba, Yasuo Takehara, Shohachi Suzuki, Hiroyuki Konno
Impact of chemotherapy-related prognostic factors on long-term survival in patients with stage III colorectal cancer after curative resection
Wen-Sy Tsai, Pao-Shiu Hsieh, Chien-Yuh Yeh, Jy-Ming Chiang, Reiping Tang, Jinn-Shiun Chen, Chung Rong Changchien, Jeng Yi Wang
Initial report of KSCC0803: feasibility study of capecitabine as adjuvant chemotherapy for stage III colon cancer in Japanese patients
Yasunori Emi, Yoshihiro Kakeji, Eiji Oki, Hiroshi Saeki, Koji Ando, Masaki Kitazono, Yoshihisa Sakaguchi, Masaru Morita, Hironori Samura, Yutaka Ogata, Yoshito Akagi, Shoji Natsugoe, Kazuo Shirouzu, Shoji Tokunaga, Florin Sirzen, Yoshihiko Maehara
Neoadjuvant treatment of mid-to-lower rectal cancer with oxaliplatin plus 5-fluorouracil and leucovorin in combination with radiotherapy: a Korean single center phase II study
Won-Suk Lee, Jeong-Heum Baek, Dong Bok Shin, Sun Jin Sym, Kwan An Kwon, Kyu Chan Lee, Seok Ho Lee, Dong Hae Jung
Metachronous colorectal cancer in Taiwan: analyzing 20 years of data from Taiwan Cancer Registry
Tzu-An Chen, Jorng-Tzong Horng, Wen-Chu Lin
A phase I trial of S-1 with concurrent radiotherapy in patients with locally recurrent rectal cancer
Hitoshi Wada, Kenji Nemoto, Takuma Nomiya, Misako Murakami, Motohisa Suzuki, Yuuki Kuroda, Mayumi Ichikawa, Ibuki Ota, Yasuhito Hagiwara, Hisanori Ariga, Ken Takeda, Kenji Takai, Keisuke Fujimoto, Masahiro Kenjo, Kazuhiko Ogawa
Feasibility of mFOLFOX6 as the adjuvant treatment after curative resection of metastases from colorectal cancer in Japanese patients
Nozomu Machida, Kouji Yoshizaki, Narikazu Boku, Kentaro Yamazaki, Yusuke Onozawa, Akira Fukutomi, Hirofumi Yasui, Keisei Taku
Frequency of fibromyalgia syndrome in breast cancer patients
Nuray Akkaya, Nilgün Simsir Atalay, Selin Taflan Selcuk, Hakan Alkan, Necdet Catalbas, Füsun Sahin
Clinicopathological significance of hypoxia-inducible factor-1 alpha (HIF-1α) expression in gastric cancer
Taro Isobe, Keishiro Aoyagi, Kikuo Koufuji, Kazuo Shirouzu, Akihiro Kawahara, Tomoki Taira, Masayoshi Kage
Erratum to: Clinicopathological significance of hypoxia-inducible factor-1 alpha (HIF-1α) expression in gastric cancer
Taro Isobe, Keishiro Aoyagi, Kikuo Koufuji, Kazuo Shirouzu, Akihiko Kawahara, Tomoki Taira, Masayoshi Kage
Prolonged treatment with three-weekly docetaxel plus daily prednisolone for metastatic castration-resistant prostate cancer: a multicenter, phase II, open-label, non-comparative, extension study in Japan
Kazuo Nishimura, Norio Nonomura, Katsuyoshi Hashine, Hiro-omi Kanayama, Seiichiro Ozono, Takeshi Miura, Tsuneharu Miki, Yoshiyuki Kakehi, Yoichi Arai, Osamu Ogawa, Ryuji Fujita, Katsuya Nonomura, Atsushi Mizokami, Senji Hoshi, Hideyuki Akaza
Definitive radiation therapy for invasive carcinoma of the vagina: impact of high-dose rate intracavitary brachytherapy
Tetsuo Nonaka, Yuko Nakayama, Nobutaka Mizoguchi, Ryo Onose, Hisamori Kato, Hiroki Nakayama
The effect of gemcitabine/paclitaxel chemotherapy on the survival of patients with metastatic urothelial cancers
Yoshiyuki Matsui, Hiroyuki Nishiyama, Koji Yoshimura, Nai-Dong Xing, Takayuki Sumiyoshi, Ryoichi Saito, Takahiro Inoue, Tomomi Kamba, Osamu Ogawa
Prognostic factors in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiation therapy
Hiroshi Okumura, Yasuto Uchikado, Masataka Matsumoto, Tetsuhiro Owaki, Yoshiaki Kita, Itaru Omoto, Ken Sasaki, Toshihide Sakurai, Tetsuro Setoyama, Bunpei Nabeki, Daisuke Matsushita, Sumiya Ishigami, Yoshiyuki Hiraki, Masayuki Nakajo, Shoji Natsugoe
Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF study
Takao Takahashi, Yoshihisa Shibata, Yuichiro Tojima, Kenji Tsuboi, Eiji Sakamoto, Katsuyuki Kunieda, Hiroshi Matsuoka, Kazuyoshi Suzumura, Mikinori Sato, Tatsushi Naganuma, Junichi Sakamoto, Satoshi Morita, Ken Kondo
Gemcitabine and carboplatin for pretreated metastatic breast cancer: the predictive value of immunohistochemically defined subtypes
Fabrizio Nelli, Luca Moscetti, Guido Natoli, Annalisa Massari, Giuliana D’Auria, Mario Chilelli, Maria Agnese Fabbri, Patrizia Frittelli, Enzo Maria Ruggeri
A Dermatitis Control Program (DeCoP) for head and neck cancer patients receiving radiotherapy: a prospective phase II study
Sadamoto Zenda, Shinobu Ishi, Mitsuhiko Kawashima, Satoko Arahira, Makoto Tahara, Ryuichi Hayashi, Seiji Kishimoto, Tomiko Ichihashi
The efficacy of caffeine-potentiated chemotherapy in clear cell sarcoma
Robin L. Jones, Anastasia Constantinidou